Simplex Trading
MDGL icon

Simplex Trading’s Madrigal Pharmaceuticals MDGL Stock Holding History

Simplex Trading’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.3M Buy
+29,200
New +$14M 0.01% 520
2025
Q4 		– Sell
-23,200
Closed -$10.6M – 9435
2025
Q3 		$10.6M Buy
23,200
+8,500
+58% +$3.17M 0.01% 927
2025
Q2 		$4.45M Sell
14,700
-900
-6% -$268K ﹤0.01% 1446
2025
Q1 		$5.17M Sell
15,600
-18,500
-54% -$6.08M ﹤0.01% 1285
2024
Q4 		$10.5M Buy
34,100
+6,400
+23% +$1.8M 0.01% 1001
2024
Q3 		$5.88M Sell
27,700
-11,700
-30% -$2.99M ﹤0.01% 1383
2024
Q2 		$11M Sell
39,400
-32,800
-45% -$7.81M 0.01% 952
2024
Q1 		$19.3M Buy
72,200
+21,600
+43% +$5.09M 0.01% 717
2023
Q4 		$11.7M Buy
50,600
+800
+2% +$140K 0.01% 986
2023
Q3 		$7.27M Buy
49,800
+11,200
+29% +$2.11M 0.01% 1104
2023
Q2 		$8.92M Sell
38,600
-4,000
-9% -$1.08M 0.01% 957
2023
Q1 		$10.3M Sell
42,600
-6,800
-14% -$1.85M 0.01% 885
2022
Q4 		$14.3M Buy
49,400
+23,400
+90% +$2.29M 0.02% 696
2022
Q3 		$1.69M Buy
26,000
+21,300
+453% +$1.48M ﹤0.01% 2108
2022
Q2 		$336K Buy
4,700
+3,500
+292% +$257K ﹤0.01% 3951
2022
Q1 		$117K Sell
1,200
-7,100
-86% -$599K ﹤0.01% 5927
2021
Q4 		$703K Buy
8,300
+5,700
+219% +$468K ﹤0.01% 3356
2021
Q3 		$258K Hold
2,600
– – ﹤0.01% 5169
2021
Q2 		$253K Buy
2,600
+2,581
+13,584% +$306K ﹤0.01% 5285
2021
Q1 		$222K Sell
19
-116
-86% -$13.5K ﹤0.01% 4594
2020
Q4 		$1.5M Buy
135
+64
+90% +$7.82K ﹤0.01% 2068
2020
Q3 		$842K Buy
71
+56
+373% +$6.08K ﹤0.01% 2425
2020
Q2 		$169K Buy
15
+4
+36% +$393 ﹤0.01% 4183
2020
Q1 		$73K Sell
11
-6
-35% -$500 ﹤0.01% 4719
2019
Q4 		$154K Sell
17
-4
-19% -$388 ﹤0.01% 4032
2019
Q3 		$181K Buy
21
+4
+24% +$375 ﹤0.01% 3669
2019
Q2 		$178K Sell
17
-80
-82% -$8.57K ﹤0.01% 3584
2019
Q1 		$1.22M Buy
97
+17
+21% +$2.11K ﹤0.01% 1824
2018
Q4 		$901K Buy
80
+23
+40% +$3.56K ﹤0.01% 1711
2018
Q3 		$1.22M Buy
+57
New +$14.3K ﹤0.01% 1693

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Simplex Trading's MDGL Position: Q4 2024 in Review

Simplex Trading sold out of Madrigal Pharmaceuticals (MDGL) in Q4 2024, closing a stake of 1,179 shares — an estimated $332K sold.

Simplex Trading first reported a position in MDGL in Q4 2014 and held it in 28 quarters. The position peaked at $5.23M in Q2 2023. 283 funds tracked by Wall St. Rank hold MDGL as of Q4 2024.

  • Simplex Trading reported no remaining Madrigal Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Simplex Trading sold 1,179 Madrigal Pharmaceuticals shares in Q4 2024, an estimated $332K.
  • Simplex Trading first reported a position in Madrigal Pharmaceuticals in Q4 2014 and held it in 28 quarters.
  • Simplex Trading's Madrigal Pharmaceuticals position peaked at $5.23M in Q2 2023.
  • 283 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q4 2024.

Based on Simplex Trading's 13F filing for Q4 2024, filed 11 Feb 2025.